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Background: Neonatal sepsis is difficult to diagnose and pathogens cannot be detected from blood cultures in
many cases. Development of a rapid and accurate method for detecting pathogens is thus essential. The main
purpose of this study was to identify etiological agents in clinically diagnosed neonatal sepsis using bacterial
ribosomal RNA-targeted reverse transcription-quantitative PCR (BrRNA-RT-qPCR) and to conduct comparisons with
the results of conventional blood culture. Since BrRNA-RT-qPCR targets bacterial ribosomal RNA, detection rates
using this approach may exceed those using conventional PCR.
Methods: Subjects comprised 36 patients with 39 episodes of suspected neonatal sepsis who underwent BrRNA-
RT-qPCR and conventional blood culture to diagnose sepsis. Blood samples were collected aseptically for BrRNA-
RT-qPCR and blood culture at the time of initial sepsis evaluation by arterial puncture. BrRNA-RT-qPCR and blood
culture were undertaken using identical blood samples, and BrRNA-RT-qPCR was performed using 12 primer sets.
Results: Positive rate was significantly higher for BrRNA-RT-qPCR (15/39, 38.5%) than for blood culture (6/39, 15.4%;
p = 0.0039). BrRNA-RT-qPCR was able to identify all pathogens detected by blood culture. Furthermore, this
method detected pathogens from neonates with clinical sepsis in whom pathogens was not detected by culture
methods.
Conclusions: This RT-PCR technique is useful for sensitive detection of pathogens causing neonatal sepsis, even in
cases with negative results by blood culture.
Background
The incidence of sepsis is higher in neonates than in
adult patients, and the risk of mortality is higher [1]. In
particular, neonates with low birth weight show rela-
tively high morbidity and mortality [2-4]. Furthermore,
neonatal sepsis is difficult to diagnose, as clinical signs
are often obscure and laboratory parameters are unspe-
cific. No clear-cut definition of neonatal sepsis has been
agreed to, although several studies have tried to identify
one [5-7]. Clinicians thus permit over-treatment based
on the high risk of mortality if sepsis is left untreated.
Normally, when the clinician suspects neonatal infection
or sepsis, blood culture and cultures of various body
sites are immediately undertaken and administration of
broad-spectrum antimicrobial agents is empirically
started. Although blood cultures are usually the basis
for a diagnosis of sepsis due to bloodstream infection,
culture results are reported after several days and sensi-
tivity is particularly low for neonates [8,9]. We have
encountered many cases in which pathogens have not
been detected from culture even though sepsis was clini-
cally suspected. Antimicrobial agents thus could not be
de-escalated, necessitating continued administration of
broad-spectrum antimicrobial agents. However, over-
administration of broad-spectrum antimicrobial agents
is associated with increased development of drug-resis-
tant microorganisms and disturbance of intestinal flora
[3,4]. In addition, prolonged initial empirical antimicro-
bial therapy may be associated with increased risk of
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birth weight neonates [2]. For these reasons, develop-
ment of pathogen-detection tools assisting blood culture
that offer more rapid results and higher sensitivity is
expected in neonatal intensive care to optimize the use
of antimicrobial agents.
PCR techniques have been used for the detection of
microorganisms from neonates with suspected sepsis
instead of blood culture [10]. PCR techniques are
becoming more useful in decreasing laboratory turn-
around times, providing results to the clinician at an
earlier stage. Several reports have described the use of
PCR-based assays for rapid and accurate identification
of bacterial DNA in the blood of neonates with sus-
pected or confirmed sepsis [1,4,11-17]. These assays rely
on PCR amplification of the 16S rRNA gene, a highly
conserved gene present in all bacterial species but
absent in humans. Although molecular assays may
improve the detection of pathogens causing sepsis, the
positivity rate for PCR in various studies of septic neo-
nates remains low [10].
The recently developed method of bacterial ribosomal
RNA-targeted reverse transcription-quantitative PCR
(BrRNA-RT-qPCR) assay has the potential to overcome
many of these problems. Matsuda et al. [18] reported
that RT-qPCR assay requires an average of only 6 h for
the quantification of various kinds of commensal bac-
teria. In addition, this approach is sensitive enough to
detect and quantify bacteria present at < 10 CFU/ml of
blood by targeting bacterial ribosomal RNA.
The purpose of the present study was to identify etio-
logical agents in clinically diagnosed neonatal sepsis
using bacterial ribosomal RNA-targeted reverse tran-
scription-quantitative PCR (BrRNA-RT-qPCR) and con-
duct comparisons with the results of conventional blood
culture. This investigation also evaluated whether the
qPCR test could detect rRNA of organisms in culture-
negative patients with neonatal sepsis.
Methods
Patients
The study was approved by the Clinical Research Ethics
Committee of Juntendo University Hospital and written
parental consent was obtained before enrolment of each
subject in the study. All included neonates were
admitted to the neonatal intensive care units (NICUs) at
Juntendo University Hospital or Juntendo University
Shizuoka Hospital between February and August 2009.
Neonatal sepsis criteria
The attending physician in each case suspected neonatal
sepsis based on a rise in C-reactive protein (CRP) and
clinical assessment of signs including fever, temperature
instability, apnea, dyspnea, cyanosis, respiratory distress,
vomiting, abdominal distension, not-doing-well, irritabil-
ity, poor feeding, and hyperglycemia. Neonates who met
two or more of these criteria were enrolled in the study.
Clinical sepsis criteria
Various neonatal sepsis criteria have been investigated
in previous reports, but have shown low sensitivity and
specificity. Therefore, no clear, accepted criteria for neo-
natal sepsis currently exist. The possibility that cases of
non-infection, local infection, viral infection and so on
might be enrolled by broad interpretation of criteria in a
judgment only assessing onset is thus a matter of con-
cern. Consequently, clinical sepsis (CSEP) was diagnosed
in a retrospective manner by two neonatologists after
each neonate was discharged from the NICU, based on
clinical course such as: two or more signs of infection;
organ dysfunction (respiratory failure, pulmonary hyper-
tension, cardiac failure, shock, renal failure, liver dys-
function, cerebral edema or thrombosis, adrenal
hemorrhage and/or insufficiency, bone marrow dysfunc-
tion and disseminated intravascular coagulopathy);
laboratory data; other cultures (urine, cerebrospinal fluid
a n dc o r db l o o d )i fc l i n i c a l l yi n d i c a t e d ;a n dt h e r a p e u t i c
response.
Sample collection and study design
In total, 1.5-3 ml of whole blood was collected asepti-
cally by arterial puncture at the time of initial sepsis
evaluation. Each sample was divided into three vials: an
RNA protective tube; an aerobic blood culture bottle;
and an anaerobic blood culture bottle. In most cases,
two blood samples from different body sites were taken
to avoid confusion caused by skin contamination, which
was likely to represent the leading cause of false-positive
results from this PCR method and to increase the likeli-
hood of bacterial detection [19].
Blood cultures
Each blood culture sample was subdivided into a two-
bottle set (92F aerobic and 93F anaerobic resin blood
culture bottles; Becton Dickinson, Tokyo, Japan), and
processed in an automatic culture device (Bactec 9240;
Becton Dickinson) within 1 h after collection at the
institutional laboratory of Juntendo University Hospital
or Juntendo University Shizuoka Hospital.
RNA preparation
Each blood sample was mixed with 2 ml of RNApro-
tect™ Bacterial Reagent (Qiagen, Hilden, Germany), and
then was set to rest at room temperature for 5 min. The
mixture was stored at -80°C until analysis. These sam-
ples were thawed at room temperature and centrifuged
at 12,000 × g and 4°C for 10 min and the supernatant
was carefully removed. The sample was resuspended in
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Sciences, Germantown, MD), 3.5 μlo fb-mercaptoetha-
n o l( S i g m a - A l d r i c h ,S t .L o u i s ,M O ) ,a n d1 0 0μlo fT r i s -
ethylenediaminetetraacetic acid (EDTA) buffer (pH 8.0).
Next, 300 mg of glass beads (diameter, 0.1 mm; BioSpec
Products, Bartlesville, OK) was added to the suspension
and processed in a high-speed homogenizer (Shake
Master, Bio Medical Science, Tokyo, Japan) for 5 min to
achieve cell lysis. Next, 500 μl of acid phenol (Wako
Pure Chemical Industries, Osaka, Japan) was added.
After incubation for 10 min at 60°C, 100 μl of chloro-
form-isoamyl alcohol was added to the mixture and cen-
trifuged at 12,000 × g and 4°C for 5 min. In the next
step, 450 μl of supernatant was collected and added to
an equal volume of chloroform-isoamyl alcohol. After
centrifugation at 12,000 × g and 4°C for 5 min, 400 μl
of the supernatant was collected. After the addition of
400 μl of isopropanol and 40 μl of 3 M sodium acetate,
the mixture was centrifuged at 15,000 × g at 4°C for 5
min. The supernatant was removed and 500 μlo f8 0 %
ethanol was added to the pellet. After centrifugation at
15,000 × g and 4°C for 2 min, the supernatant was
removed and the pellet was dried. Finally, the nucleic
acid fraction was suspended in 100 μl of nuclease-free
water.
Primers
Numerous 16S rRNA gene sequences have been
described previously. Sequences used in the present
study were as follows: Streptococcus agalactiae forward:
s-Sag-F, reverse: g-Sag-R [20]; genus Staphylococcus for-
ward: STPYF, reverse: STPYR2 [21]; genus Enterococcus
forward: g-Encoc-F, reverse: g-Encoc-R [18]; family
Enterobacteriaceae forward: En-lsu-3F, reverse: En-lsu-
3R [18]; genus Pseudomonas forward: PSD7F, reverse:
PSD7R [18]; Bacillus cereus forward: S-S-Bc-200-a.S-18
[22], reverse: Bc2R [22,23]; Bacteroides fragilis group
forward: g-Bfra-F2, reverse: g-Bfra-R [24]; Atopobium
cluster forward: c-Atopo-F, reverse: c-Atopo-R [24];
Clostridium coccoides group forward: g-Ccoc-F, reverse:
g-Ccoc-R [24]; Clostridium leptum subgroup forward:
sg-Clept-F, reverse: sg-Clept-R3 [24]; Clostridium per-
fringens forward: s-Clper-F, reverse: ClPER-R [24]; genus
Bifidobacterium forward: g-Bifid-F, reverse: g-Bifid-R
[24]; and genus Prevotella forward: g-Prevo-F, reverse:
g-Prevo-R [24].
RT-qPCR
T h eR T - q P C Ra s s a yw a sp e r f o r m e du s i n gt h em e t h o d s
described previously by Matsuda et al. [18]. The RT-
qPCR assay was performed using a One Step RT-PCR
kit (Qiagen). Amplification reactions were performed in
a volume of 20 μlc o n t a i n i n g2μl of template RNA, 1 ×
OneStep RT-PCR Buffer (Qiagen), deoxynucleoside
triphosphate at a concentration of 0.5 mM, 1:100,000
dilution of SYBR green I (BioWhittaker Molecular
Applications, Rockland, ME), 0.8 μl of OneStep RT-PCR
Enzyme mixture (Qiagen) and each of the specific pri-
mers at a concentration of 0.75 μM. The reaction mix-
ture was incubated at 50°C for 30 min for reverse
transcription. The continuous amplification program
consisted of one cycle at 95°C for 15 min, followed by
40 cycles at 94°C for 20 s, 60°C (Staphylococcus, Entero-
bacteriaceae, Pseudomonas, Bacillus cereus, S. agalac-
tiae), 55°C (Enterococcus, Clostridium coccoides group,
Clostridium leptum, Atopobium cluster, Prevotella, Bifi-
dobacterium )o r5 0 ° C( Bacteroides fragilis group) for
20 s and 72°C for 50 s. Fluorescent products were
detected in the last step of each cycle. Both amplifica-
tion and detection were performed using an ABI PRISM
7500HT sequence detection system (Applied Biosystems,
Foster City, CA).
Determination of the number of bacteria in a sample
was performed essentially as described previously
[18,24]. A calibration curve was constructed by estab-
lishing a threshold line and plotting the threshold cycle
(Ct) value, representing the cycle number at which
threshold fluorescence was reached, and then the corre-
sponding cell count was determined using a Sequence
Detection System (Applied Biosystems). The entire
BrRNA-RT-qPCR assay, including the RNA extraction
step, could be completed in about 6 h.
Statistical analysis
Results were analyzed using SAS version 8.02 software
(CISCO, Tokyo, Japan). Quantitative data are presented
as mean ± standard deviation. McNemar’s test with con-
tinuity correction was performed to analyze associations
between the results of BrRNA-RT-qPCR and blood cul-




Individual patient characteristics are summarized in
Additional file 1. A total of 65 samples were obtained
from 36 patients throughout the 39 episodes of neonatal
sepsis in this study. Double samples from different body
sites were able to be taken from 24 patients with 26 sep-
t i ce p i s o d e s ,w h i l eo n l yas i n g l es a m p l ew a so b t a i n e d
from 12 cases with 13 episodes due to technical pro-
blems. Moreover, we excluded repeated samples taken
in the same episode.
Result of BrRNA-RT-qPCR compared to blood culture in
total patients
The positive rate was significantly higher for BrRNA-
RT-qPCR (15/39, 38.5%) than for blood culture (6/39,
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of pathogens detected by BrRNA-RT-qPCR are shown
in Additional file 3. Blood culture detected pathogens in
six of 39 episodes, identifying Staphylococcus epidermi-
dis (n = 2), Klebsiella pneumonia (n = 3), Enterobacter
cloacae (n = 1) and Pseudomonas aeruginosa (n = 1).
BrRNA-RT-qPCR could detect pathogens in 15 of 39
episodes, identifying Staphylococcus (n = 2), Enterobac-
teriaceae (n = 11), Pseudomonas (n = 1) and Clostri-
dium leptum subgroup (n = 1) in the PCR-positive
group. In all six blood culture-positive episodes,
BrRNA-RT-qPCR detected the same type of bacteria as
that identified by the culture. Polymicrobial infection
was identified by both PCR and blood culture in one
e p i s o d e( C a s e2 7 ) .I n9o ft h e1 5e p i s o d e si nw h i c h
pathogens were detected by BrRNA-RT-qPCR, culture
method could not detect pathogens from blood.
Result of BrRNA-RT-qPCR in comparison to blood culture
in patients with blood samples obtained from two sites
and clinical diagnosis
Blood samples were obtained from two sites in 26 epi-
sodes with suspected neonatal sepsis. The positive rate
was significantly higher for BrRNA-RT-qPCR (10/26,
38.5%) than for blood culture (3/26, 11.5%; p = 0.0156).
All three culture-positive/PCR-positive episodes showed
clinical sepsis. Seven of the 26 episodes that were posi-
tive according to PCR, but showed negative results from
blood culture are presented in Additional file 4. Among
those, four cases (Cases 4, 5, 7 and 9) clearly displayed
clinical sepsis and disseminated intravascular coagula-
tion (DIC) (Additional file 4). In Case 4, > 10
5 CFU/mL
of E. coli was detected in urine collected through a
catheter, and presence of Enterobacteriaceae consistent
with E. coli was detected according to the results of the
present PCR method. In Case 7, E. coli was identified
from maternal umbilical blood culture, and the present
PCR method of a blood sample from the neonate
detected Enterobacteriaceae consistent with E. coli.
Cases 5 and 9 were severe cases of sepsis with DIC, but
blood cultures were negative. The other 16 episodes
showed culture-negative/PCR-negative results, but three
of these episodes were diagnosed with clinical sepsis.
Discussion
Reasons for lower sensitivity of blood culture are related
to the low numbers of bacteria within the bloodstream,
the small volumes of blood obtained from neonates for
culture, and the increasingly common practice of pro-
viding intrapartum antibiotic prophylaxis to mothers of
high-risk deliveries and high-risk neonates [4,14,25,26].
Further efforts toward the development of methods to
detect neonatal sepsis are thus focused on improving
sensitivity, shortening the identification time for
pathogens and improving optimized use of antibiotics.
A rapid diagnosis of neonatal sepsis permits earlier
administration of appropriate antimicrobial agents and
reduces morbidity and mortality. The 16S rDNA
sequencing offer the following advantages over blood
cultures: 1) use of smaller volumes of blood; 2) produc-
tion of results within a shorter turnaround time; 3) abil-
ity to detect a small amount of bacteria; and 4) reduced
likelihood of effects from prior antimicrobial therapy.
However, various studies of neonatal sepsis have
reported no significant difference between blood culture
and PCR targeting rDNA, and the detection rate of
PCR techniques reportedly shows a range of 3-29%
[1,10,11,13,16,17].
On the other hand, BrRNA-RT-qPCR may represent a
m o r es e n s i t i v em e t h o db yt a r g e t i n gr i b o s o m a lR N A .
Matsuda et al. [18] had focused on rRNA as the target
for precise and sensitive quantification of commensal
subdominant bacterial populations, since rRNA is a uni-
versal constituent of bacterial ribosomes and high copy
numbers (10
3-10
4 molecules per actively growing cell)
are present as housekeeping genes. In peripheral blood,
the lower detection limit for BrRNA-RT-qPCR quantifi-
cation of bacteria was 2 cells/ml of blood. Sensitivity
was approximately 10- to 100-fold higher than that of
conventional PCR methods [18]. In this study, the detec-
tion rate using this BrRNA-RT-qPCR assay was much
higher than the conventional blood culture in neonatal
sepsis. One pathogenic cell per milliliter of culture
could be detected using this method. This is the first
study in which 16S ribosomal RNA-targeted RT-qPCR
was used in neonatal sepsis to detect bacterial patho-
gens; other studies have performed detection using 16S
rRNA gene or rDNA. Moreover, the distribution of
pathogens isolated from neonatal sepsis is based on a
result of blood cultures with lower sensitivity. In this
study, Enterobacteriaceae were detected most from
blood samples. This indicates the possibility that the fre-
quency of pathogens for neonatal sepsis based on this
method differs from results based on blood culture.
Enormous variance in antibiotic susceptibility exists
between some genera in the family Enterobacteriaceae,
but clarification of genus information enables suspen-
sion of unnecessary antibiotics, such as suspending use
of vancomycin for patients showing methicillin-resistant
Staphylococcus aureus. We are planning to develop pri-
mers suitable for discriminating between these genera.
Since no widely accepted definition of neonatal sepsis
has been created, the criteria for neonatal sepsis may
differ between institutions and clinicians. Detection
rates of pathogens from the bloodstream also vary
between institutions. We therefore cannot simply com-
pare the sensitivity of this method with previous PCR
methods. However, this method showed a detectability
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this study. Methods offering more sensitivity than this
method in comparison with blood culture have not been
reported previously. Clinical applications thus appear
feasible for this method.
To confirm the clinical efficacy of this method, we ret-
rospectively reviewed the clinical courses of 26 episodes
for which two sets of blood samples had been taken.
Seven of 26 episodes showed positive detection of
pathogens using this method, despite negative blood cul-
tures. In the field of neonatal care, cases that test nega-
tive in blood cultures despite clinical suspicion of sepsis
have become a problem [5]. If prompt specification of
pathogens in such cases becomes possible, the present
method would be clinically important and may also
facilitate selection of the most appropriate treatment. In
particular, molecular techniques are considered more
useful than traditional methods for those cases in which
the use of antimicrobial agents that make blood cultures
prone to negative results has been initiated and for
c a s e sw i t hs m a l la m o u n t so fp a t h o g e nt h a ta r ed i f f i c u l t
to culture and sample [14]. Regarding the remaining
three cases (Cases 6, 8 and 10), increased inflammatory
reactions were observed in all cases, but obvious infec-
tious signs were observed irritability in Cases 6 and 10.
All these cases were initially suspected as maternal and
intrauterine infection, and antimicrobial agents had
already been administered to the mothers. Furthermore,
onset was within 24 h of birth in all cases. Pathogens
were considered to have avoided detection and no
obvious symptoms were observed due to the administra-
tion of antimicrobial agents to the mothers. Three of
the other 16 episodes showing culture-negative/PCR-
negative results were clinically diagnosed clinical sepsis.
Three of 16 episodes with negative results for both
blood culture and PCR were actually diagnosed as sep-
sis. These were identified as false-negative results for the
following reasons: 1) microorganisms in the bloodstream
are not generally distributed in a uniform manner and
may not be captured from only a small blood sample; 2)
our PCR primers may not cover all of the pathogens at
the present time; and 3) our primers could not cover
fungi, which have become a larger problem in neonatal
sepsis. Improvements in primers for detecting bacteria
and fungi remains a major issue to be addressed in
future studies. At present, BrRNA-RT-qPCR is expen-
sive and labor-intensive. In the future, we plan to create
a simple and compact system for detecting pathogens in
hospital settings.
Conclusions
As neonatal sepsis has to be diagnosed based on a lim-
ited sample volume, it is a very difficult diagnosis to
make. Under these circumstances, identification of
pathogens within approximately 6 h using only 0.5 ml of
blood would facilitate prompt diagnosis and treatment
of neonatal sepsis. According to the above results,
BrRNA-RT-qPCR appears to provide prompt findings
with higher detection sensitivity as compared to blood
culturing, indicating the possibility that this method is a
useful adjunct to blood culture for diagnosing neonatal
sepsis.
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